The role of TLRs in cervical cancer with HPV infection: a review

被引:75
作者
Yang, Xiao [1 ]
Cheng, Yanxiang [1 ,2 ]
Li, Chunsheng [2 ]
机构
[1] Wuhan Univ, Dept Obstet & Gynecol, Renmin Hosp, Wuhan, Hubei, Peoples R China
[2] Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
中国国家自然科学基金;
关键词
TOLL-LIKE RECEPTORS; MONOPHOSPHORYL-LIPID-A; NF-KAPPA-B; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS; NITRIC-OXIDE; CELL-PROLIFERATION; EXPRESSION; ACTIVATION; VACCINES;
D O I
10.1038/sigtrans.2017.55
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The main cause of cervical cancer is persistent infection with high-risk human papilloma virus (HR-HPV), but not all human papilloma virus (HPV) infections lead to cervical cancer. The key factors that determine the outcome of HPV infection remain poorly understood, and how the host immune system protects against HPV infection is unclear. Toll-like receptors (TLRs) are a group of pattern recognition receptors present in the cytoplasm and cell membrane, and can specifically recognize pathogen-associated molecular patterns. As the key molecules of innate and acquired immunity, TLRs not only play important roles in the immune defense against infectious diseases, but also are involved in the occurrence and development of a variety of malignant tumors. In cervical cancer caused by HR-HPV infection, TLRs have been found to regulate the local immune microenvironment. The role of TLRs in HR-HPV infection and HPV-induced cervical cancer and its relationship with HPV vaccine are reviewed in this article.
引用
收藏
页数:10
相关论文
共 99 条
  • [1] Polymorphisms of glutathione S-transferase 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility
    Al-Harras, Mohammad F.
    Houssen, Maha E.
    Shaker, Mohamed E.
    Farag, Kamel
    Farouk, Omar
    Monir, Rehan
    El-Mahdy, Rasha
    Abo-Hashem, Ekbal M.
    [J]. ONCOLOGY LETTERS, 2016, 11 (03) : 2182 - 2188
  • [2] Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
    Alexopoulou, L
    Holt, AC
    Medzhitov, R
    Flavell, RA
    [J]. NATURE, 2001, 413 (6857) : 732 - 738
  • [3] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [4] Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
    Cai, Zhenyu
    Sanchez, Amir
    Shi, Zhongcheng
    Zhang, Tingting
    Liu, Mingyao
    Zhang, Dekai
    [J]. CANCER RESEARCH, 2011, 71 (07) : 2466 - 2475
  • [5] TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections
    Cannella, Fabiana
    Pierangeli, Alessandra
    Scagnolari, Carolina
    Cacciotti, Giulia
    Tranquilli, Giulia
    Stentella, Patrizia
    Recine, Nadia
    Antonelli, Guido
    [J]. IMMUNOBIOLOGY, 2015, 220 (03) : 363 - 368
  • [6] The phosphoinositide 3-kinase pathway
    Cantley, LC
    [J]. SCIENCE, 2002, 296 (5573) : 1655 - 1657
  • [7] A20 in inflammation and autoimmunity
    Catrysse, Leen
    Vereecke, Lars
    Beyaert, Rudi
    van Loo, Geert
    [J]. TRENDS IN IMMUNOLOGY, 2014, 35 (01) : 22 - 31
  • [8] Cheng Y., 2013, J. Cancer Ther, V4, P549, DOI [10.4236/jct.2013.42069, DOI 10.4236/JCT.2013.42069]
  • [9] Cluff CW, 2009, ADV EXP MED BIOL, V667, P111, DOI 10.1007/978-1-4419-1603-7_10
  • [10] Toll-like receptors and T-helper-1/T-helper-2 responses
    Dabbagh, K
    Lewis, DB
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (03) : 199 - 204